Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Atherosclerosis. Supplements
|
January 30, 2013
Current standards in diagnosis and therapy of hyperlipoproteinemia
S Fischer, U Schatz, U Julius
Atherosclerosis. Supplements
|
May 5, 2015
Practical recommendations for the management of hyperlipidemia
S Fischer, U Schatz, U Julius
Journal of Experimental Psychology. Human Perception and Performance
|
June 27, 2001
Validity and boundary conditions of automatic response activation in the Simon task
E Wascher, U Schatz, T Kuder, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden
J Dittrich-Riediger, U Schatz, B Hohenstein, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Effects of different lipoprotein apheresis methods on serum protein levels
U Julius, G Siegert, H Kostka, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a)-an interdisciplinary challenge
U Julius, S Tselmin, U Schatz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 29, 2014
[Lipoprotein(a): a risk factor for atherosclerosis]
S Fischer, U Julius, S Tselmin, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
U Julius, S Tselmin, U Schatz, et al.
Atherosclerosis. Supplements
|
November 4, 2017
Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemia
S Tselmin, G Müller, U Schatz, et al.
Atherosclerosis. Supplements
|
November 4, 2017
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational study
U Schatz, S Tselmin, G Müller, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Atherosclerosis. Supplements
|
January 30, 2013
Current standards in diagnosis and therapy of hyperlipoproteinemia
S Fischer, U Schatz, U Julius
Atherosclerosis. Supplements
|
May 5, 2015
Practical recommendations for the management of hyperlipidemia
S Fischer, U Schatz, U Julius
Journal of Experimental Psychology. Human Perception and Performance
|
June 27, 2001
Validity and boundary conditions of automatic response activation in the Simon task
E Wascher, U Schatz, T Kuder, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden
J Dittrich-Riediger, U Schatz, B Hohenstein, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Effects of different lipoprotein apheresis methods on serum protein levels
U Julius, G Siegert, H Kostka, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a)-an interdisciplinary challenge
U Julius, S Tselmin, U Schatz, et al.
Deutsche Medizinische Wochenschrift (1946)
|
May 29, 2014
[Lipoprotein(a): a risk factor for atherosclerosis]
S Fischer, U Julius, S Tselmin, et al.
Clinical Research in Cardiology Supplements
|
March 7, 2019
Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors
U Julius, S Tselmin, U Schatz, et al.
Atherosclerosis. Supplements
|
November 4, 2017
Kinetics of Lipoprotein(a) in patients undergoing weekly lipoprotein apheresis for Lp(a) hyperlipoproteinemia
S Tselmin, G Müller, U Schatz, et al.
Atherosclerosis. Supplements
|
November 4, 2017
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels - A multicenter observational study
U Schatz, S Tselmin, G Müller, et al.
Page
of 2